Prior Art Litigation Search in Vancouver.

A prior art search Vancouver litigation counsel can rely on has to be built for a system unlike Europe or the United States — Canada puts patent validity in the hands of a single national court and does not split validity from infringement. Vancouver falls within the western jurisdiction of the Federal Court of Canada, which holds a registry in the city and is the only court that can strike a Canadian patent from the register with in rem effect. British Columbia’s superior court can hear infringement, but not validity. The city is also Canada’s fuel-cell, cleantech, biotech and mining-technology capital, so the patents asserted here read on hydrogen systems, antibodies, batteries, software and mineral-processing methods. PerspireIP builds invalidity-grade searches for the accused parties challenging those patents before the Federal Court and CIPO.

Where a prior art search Vancouver case is actually heard

Canada resolves patent disputes very differently from Europe. There is no Unified Patent Court, no European-style opposition, and no split forum for validity and infringement. Almost every significant patent fight is heard in the Federal Court of Canada, a single national trial court that sits across the country and maintains a registry in Vancouver serving British Columbia and the western provinces. A defendant sued here does not navigate a patchwork of provincial procedures; the case is governed by one federal set of rules and one specialised IP bench.

The Federal Court has exclusive jurisdiction over impeachment — an action to have a patent declared invalid — and it is the only court that can order a Canadian patent void with effect against the world (in rem), correcting the register at CIPO. IP matters are frequently assigned to judges in the court’s IP chambers, who bring specialised patent experience. That concentration is exactly why the invalidity record has to be built to a national trial standard from the outset.

• Federal Court of Canada — Vancouver registry — national jurisdiction over patent validity and infringement; the only forum that can invalidate a patent in rem
• Supreme Court of British Columbia — a provincial superior court that can hear patent infringement, but cannot declare a patent invalid on the register
• Canadian Intellectual Property Office (CIPO) — grants Canadian patents and runs the administrative re-examination route
• Federal Court of Appeal — hears appeals from Federal Court patent judgments before the Supreme Court of Canada

The Federal Court decides validity — provincial courts cannot

The single most important structural fact for an accused party in Vancouver is where validity can be decided. Both the Federal Court and a provincial superior court such as the Supreme Court of British Columbia can hear patent infringement. But only the Federal Court can declare a patent invalid and strike it from the register with effect against everyone. A provincial court can, at most, find a patent unenforceable as between the two parties in front of it (in personam) — it cannot clear the patent off the register for the whole market.

For a defendant whose real goal is to kill the patent, that makes the Federal Court the venue of choice. An impeachment action — or a validity counterclaim inside a Federal Court infringement suit — delivers a result that binds every competitor, not just the parties to the case. It is also why the great majority of contested patent litigation in Canada is filed in the Federal Court rather than provincially: the remedy is broader and the bench is specialised.

Whichever route you choose, the case turns on the same thing — the prior art. Novelty and obviousness are decided on the references put before the judge, and in Canada that record is assembled through documentary discovery and expert evidence, then tested at trial. Art produced late or poorly dated does not survive that process. Building it correctly the first time is decisive.

No bifurcation: validity and infringement are heard together

Unlike Germany or Poland, Canada does not bifurcate validity and infringement. When a patent is asserted in the Federal Court, the defendant typically counterclaims for invalidity, and the same judge decides both issues in one proceeding on one evidentiary record. There is no separate patent office tribunal that must first rule on validity before the infringement court can act. That unified structure shapes how a defence — and the prior-art search behind it — has to be scoped.

The bifurcation that does occur in Canadian patent cases is different: courts often split liability from the quantification of monetary remedies, trying whether the patent is valid and infringed first, and leaving the accounting of damages or profits to a later phase. Validity and infringement stay together in the liability trial. For an accused party, this means the invalidity case cannot be treated as a fallback raised only if infringement is found — it is litigated head-on, at the same time, before the same judge.

Practically, that raises the bar on the prior art. It has to be trial-ready when the liability phase opens, charted claim by claim against novelty and obviousness under the Canadian Patent Act, and supported by expert evidence a Federal Court judge can follow. A rigorous search feeds both the validity counterclaim and the non-infringement position at once.

CIPO re-examination and the absence of post-grant opposition

Canada does not offer a broad post-grant opposition of the kind the EPO runs, and it has no inter partes review like the United States. The administrative route is re-examination at CIPO. Any person — including an accused infringer — may ask the Commissioner of Patents to re-examine one or more claims of a granted patent at any time during its term, and a re-examination board of patent examiners then reviews them.

The route is deliberately narrow. A re-examination request must be grounded in prior-art patents, published applications or printed publications, and it can only challenge claims on anticipation (novelty) or obviousness. It cannot raise insufficiency, ambiguity, overbreadth or lack of utility — those grounds live only in the Federal Court. Because the ground is limited to documentary prior art, the quality of the references is everything: re-examination is won or lost on whether the art squarely anticipates or renders the claims obvious.

Re-examination and Federal Court impeachment are not mutually exclusive. Canadian courts have confirmed that a re-examination board decision does not preclude a later validity challenge in court on the same grounds — the Federal Court retains exclusive jurisdiction over validity. The strategic value of a strong search is therefore that the same charted references can drive a fast, low-cost CIPO re-examination and, if needed, anchor a full Federal Court impeachment action.

PM(NOC) pharma and biotech linkage litigation

Vancouver’s biotech strength means many of its patent fights run through Canada’s pharmaceutical linkage system, the Patented Medicines (Notice of Compliance) Regulations, known as PM(NOC). These proceedings are brought exclusively in the Federal Court and work much like the U.S. Hatch-Waxman framework: when a generic or biosimilar maker serves a Notice of Allegation attacking the patents listed against a reference drug, the patentee has 45 days to start an action, and the Regulations target roughly a two-year timeline to decide infringement and validity together.

The Regulations cover both small-molecule pharmaceuticals and biologics, which matters directly to Vancouver’s antibody and protein-therapeutics companies. For a generic or biosimilar sponsor, the invalidity case has to be ready on a compressed clock, and formulation, dosage-regimen, second-medical-use and antibody-sequence claims each hide their decisive prior art in a different place — journal literature, clinical-trial registries, regulatory filings and older patent families.

Because a PM(NOC) action and a conventional impeachment action turn on the same novelty and obviousness analysis, one properly built prior-art file can serve both. We size the search to the PM(NOC) timetable and to the specific claim types in the listed patents.

What Vancouver’s cleantech, biotech and mining-tech patents read on

Vancouver is the centre of Canada’s clean-energy and life-sciences invention, and its patent docket reflects that mix. Metro Vancouver hosts the world’s densest hydrogen and fuel-cell cluster — Ballard Power Systems, Westport Fuel Systems and General Fusion among them — alongside an antibody and protein-therapeutics hub anchored by AbCellera and Zymeworks, a large software and gaming sector, and the head offices of much of Canada’s mining and mineral-processing industry. Each field produces a distinct kind of patent claim.

• Fuel cells and cleantech — membrane-electrode assemblies, catalysts, stack architectures, hydrogen storage, gas-injection and battery-system claims from the Ballard/Westport/General Fusion ecosystem
• Biotech and pharma — antibody sequences, protein engineering, formulations and dosage regimens from AbCellera, Zymeworks and the wider life-sciences cluster, often litigated under PM(NOC)
• Software and gaming — interfaces, data-processing methods and networking, where the art hides in code and documentation rather than patents
• Mining and mineral-processing technology — extraction, ore-processing and instrumentation claims from Vancouver’s mining head-office and junior-explorer base

Vancouver companies also file heavily in the United States, so the assertions here sit inside cross-border patent families. A search built for a fuel-cell catalyst claim looks nothing like one built for an antibody or a mineral-processing method, and the accused party is just as likely to be a cleantech scale-up or a biosimilar maker as a software house. Treating those subject-matters the same is how invalidity cases are lost.

Where the decisive prior art lives — and how PerspireIP builds it

The reference that kills a claim is rarely a headline patent. In Vancouver’s fuel-cell, biotech and software disputes it often sits outside the patent databases entirely, and proving exactly when it became public is half the battle — a disclosure is only prior art if it can be shown to predate the priority date. We search patents and non-patent literature in parallel and treat the public-availability date of every reference as evidence to be established.

• Fuel cells and cleantech — ECS and electrochemistry proceedings, materials-science journals, conference papers, datasheets and older patent families argued as obviousness combinations
• Biotech — journal literature, clinical-trial registries, sequence databases, regulatory and pharmacopoeia records and conference abstracts
• Software and gaming — source repositories and commit history, SDK and API documentation, changelogs, archived product pages and standards specifications
• Dating evidence — web-archive captures, repository timestamps and library accession records used to fix a public-availability date to the day

Every engagement follows the same disciplined path. We map the asserted claims element by element, fix the priority date that actually governs each one, and search against that date rather than the filing date on the cover. For a Vancouver dispute we scope the work to the real forum — a Federal Court impeachment action or validity counterclaim, a CIPO re-examination, or a PM(NOC) proceeding — and we build claim charts a Federal Court judge, a re-examination board or your expert can follow.

We work alongside your Canadian and cross-border counsel as a specialist search partner, deliver to Federal Court and CIPO deadlines, and keep every engagement confidential. Whether you are a cleantech scale-up, a biosimilar sponsor or litigation counsel preparing an invalidity counterclaim, send us the patent number and your key dates, and we will scope a prior art search Vancouver project within one business day.

IP Landscape & Resources in Vancouver

Key intellectual-property authorities and venues relevant to Vancouver:

• Canadian Intellectual Property Office (CIPO) — the Canadian patent office; grants Canadian patents, maintains the register and runs the administrative re-examination route for challenging claims on novelty or obviousness
• Federal Court of Canada — the national trial court with jurisdiction over patent validity and infringement and exclusive power to invalidate a patent in rem through an impeachment action; holds a registry in Vancouver
• World Intellectual Property Organization (WIPO) — administers the PCT international filing route Canadian applicants use and hosts global patent and non-patent literature databases used in prior-art searching
• Canadian Patents Database — CIPO's public patent register, used to pull the file history, claims and priority dates of the asserted Canadian patent

Request a Prior Art Search in Vancouver

Explore related PerspireIP services: Prior Art Litigation Search · Patent Invalidation · Patent Infringement Analysis.

Frequently Asked Questions